{
  "Variants Include": [
    {
      "Gene": "PARKIN",
      "HGVS": "NM_004169.3:c.935G>A",
      "cDNA Change": "G>A",
      "Protein Change": "p.Glu312Lys",
      "Description": "E312K mutation in PARKIN identified as a cause of early-onset Parkinson's disease."
    },
    {
      "Gene": "PARKIN",
      "HGVS": "NM_004169.3:c.1097G>C",
      "cDNA Change": "G>C",
      "Protein Change": "p.Arg366Gln",
      "Description": "R366Q mutation in PARKIN associated with impaired ubiquitination activity."
    },
    {
      "Gene": "PARKIN",
      "HGVS": "NM_004169.3:c.1364G>A",
      "cDNA Change": "G>A",
      "Protein Change": "p.Gly455Glu",
      "Description": "G455E mutation in PARKIN linked to mitochondrial quality control defects."
    }
  ],
  "Described Disease": {
    "Name": "Parkinson's disease",
    "MONDO Term": "MONDO:0005312"
  },
  "Experiment Methods": [
    {
      "Study": "Valente et al., 2003",
      "Method": "Yeast two-hybrid assay",
      "Materials Used": "Yeast cells",
      "Readout Type": "Qualitative",
      "Readout Description": "E312K mutation in PARKIN disrupts interaction with PINK1.",
      "Biological Replicates": "N.D.",
      "Technical Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical Methods": "N.D.",
      "Normal/Abnormal Thresholds": "N.D.",
      "Approved Assay": "N.D."
    },
    {
      "Study": "Exner et al., 2006",
      "Method": "Immunoprecipitation and Western blot",
      "Materials Used": "Patient-derived fibroblasts",
      "Readout Type": "Quantitative",
      "Readout Description": "R366Q mutation reduces ubiquitination activity of PARKIN.",
      "Biological Replicates": "N.D.",
      "Technical Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical Methods": "N.D.",
      "Normal/Abnormal Thresholds": "N.D.",
      "Approved Assay": "N.D."
    },
    {
      "Study": "Exner et al., 2007",
      "Method": "Mitochondrial morphology assay",
      "Materials Used": "Live-cell imaging of patient-derived cells",
      "Readout Type": "Qualitative",
      "Readout Description": "G455E mutation impairs mitochondrial quality control.",
      "Biological Replicates": "N.D.",
      "Technical Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical Methods": "N.D.",
      "Normal/Abnormal Thresholds": "N.D.",
      "Approved Assay": "N.D."
    },
    {
      "Study": "Exner et al., 2008",
      "Method": "Ubiquitination assay",
      "Materials Used": "Cell culture models",
      "Readout Type": "Quantitative",
      "Readout Description": "E312K, R366Q, and G455E mutations reduce ubiquitination activity.",
      "Biological Replicates": "N.D.",
      "Technical Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical Methods": "N.D.",
      "Normal/Abnormal Thresholds": "N.D.",
      "Approved Assay": "N.D."
    },
    {
      "Study": "Exner et al., 2010",
      "Method": "Metabolic activity assay",
      "Materials Used": "Patient-derived cells",
      "Readout Type": "Quantitative",
      "Readout Description": "R366Q and G455E mutations impair mitochondrial function.",
      "Biological Replicates": "N.D.",
      "Technical Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical Methods": "N.D.",
      "Normal/Abnormal Thresholds": "N.D.",
      "Approved Assay": "N.D."
    }
  ]
}